1. A method for assessing pulmonary gas exchange and/or thickening or function of the blood-gas barrier, comprising: obtaining dissolved phase hyperpolarized 129 Xe NMR spectra having peaks associated with red blood cells (RBC); obtaining dissolved phase hyperpolarized 129 Xe MRI spectra having peaks associated with a blood-gas barrier; and electronically evaluating the RBC and barrier spectra peaks.